
Panelists consider at what point in the disease development patients typically access the health care system for diagnosis and treatment.
Panelists consider at what point in the disease development patients typically access the health care system for diagnosis and treatment.
A discussion on the various unmet needs in the treatment of Alzheimer disease.
Key opinion leaders discuss the clinical burden for a patient with Alzheimer disease and enumerate available drug and nondrug treatment options.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.